BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22427680)

  • 1. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury.
    Lee YJ; Han JY; Byun J; Park HJ; Park EM; Chong YH; Cho MS; Kang JL
    J Leukoc Biol; 2012 Jun; 91(6):921-32. PubMed ID: 22427680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation.
    Choi JY; Park HJ; Lee YJ; Byun J; Youn YS; Choi JH; Woo SY; Kang JL
    J Pharmacol Exp Ther; 2013 Feb; 344(2):447-58. PubMed ID: 23197771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis.
    Fielhaber JA; Carroll SF; Dydensborg AB; Shourian M; Triantafillopoulos A; Harel S; Hussain SN; Bouchard M; Qureshi ST; Kristof AS
    J Immunol; 2012 May; 188(9):4535-42. PubMed ID: 22450807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages.
    Prêle CM; Woodward EA; Bisley J; Keith-Magee A; Nicholson SE; Hart PH
    J Immunol; 2008 Dec; 181(11):8018-26. PubMed ID: 19017994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src tyrosine kinases mediate activations of NF-kappaB and integrin signal during lipopolysaccharide-induced acute lung injury.
    Lee HS; Moon C; Lee HW; Park EM; Cho MS; Kang JL
    J Immunol; 2007 Nov; 179(10):7001-11. PubMed ID: 17982091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway.
    Hua F; Ren W; Zhu L
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):480-6. PubMed ID: 21577093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice.
    Fu K; Piao T; Wang M; Zhang J; Jiang J; Wang X; Liu H
    Int Immunopharmacol; 2014 Dec; 23(2):400-6. PubMed ID: 25063711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes.
    Dai X; Sayama K; Tohyama M; Shirakata Y; Yang L; Hirakawa S; Tokumaru S; Hashimoto K
    Int Immunol; 2008 Jul; 20(7):901-9. PubMed ID: 18492658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GADD34 suppresses lipopolysaccharide-induced sepsis and tissue injury through the regulation of macrophage activation.
    Ito S; Tanaka Y; Oshino R; Okado S; Hori M; Isobe KI
    Cell Death Dis; 2016 May; 7(5):e2219. PubMed ID: 27171261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paralemmin-3 contributes to lipopolysaccharide-induced inflammatory response and is involved in lipopolysaccharide-Toll-like receptor-4 signaling in alveolar macrophages.
    Chen XX; Tang L; Fu YM; Wang Y; Han ZH; Meng JG
    Int J Mol Med; 2017 Dec; 40(6):1921-1931. PubMed ID: 29039447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
    Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
    Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
    Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
    Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.
    Kim TW; Joh EH; Kim B; Kim DH
    Int Immunopharmacol; 2012 Jan; 12(1):110-6. PubMed ID: 22107725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
    Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
    Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
    Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.
    Serezani CH; Lewis C; Jancar S; Peters-Golden M
    J Clin Invest; 2011 Feb; 121(2):671-82. PubMed ID: 21206089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
    Tang Y; Chen Y; Chu Z; Yan B; Xu L
    Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.
    Joh EH; Gu W; Kim DH
    Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.